- Home
- IBRX vs BKE Comparison
IBRX vs BKE Comparison
Compare IBRX & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- BKE
- Stock Information
- Founded
- IBRX 2014
- BKE 1948
- Country
- IBRX United States
- BKE United States
- Employees
- IBRX N/A
- BKE N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- BKE Clothing/Shoe/Accessory Stores
- Sector
- IBRX Health Care
- BKE Consumer Discretionary
- Exchange
- IBRX Nasdaq
- BKE Nasdaq
- Market Cap
- IBRX 2.4B
- BKE 2.6B
- IPO Year
- IBRX N/A
- BKE 1992
- Fundamental
- Price
- IBRX $2.81
- BKE $51.53
- Analyst Decision
- IBRX Buy
- BKE Hold
- Analyst Count
- IBRX 2
- BKE 1
- Target Price
- IBRX $17.38
- BKE $46.00
- AVG Volume (30 Days)
- IBRX 5.6M
- BKE 422.3K
- Earning Date
- IBRX 11-12-2024
- BKE 11-22-2024
- Dividend Yield
- IBRX N/A
- BKE 2.71%
- EPS Growth
- IBRX N/A
- BKE N/A
- EPS
- IBRX N/A
- BKE 3.94
- Revenue
- IBRX $7,332,000.00
- BKE $1,220,873,000.00
- Revenue This Year
- IBRX $2,572.99
- BKE N/A
- Revenue Next Year
- IBRX $747.59
- BKE $2.38
- P/E Ratio
- IBRX N/A
- BKE $13.13
- Revenue Growth
- IBRX 1218.71
- BKE N/A
- 52 Week Low
- IBRX $2.82
- BKE $34.87
- 52 Week High
- IBRX $10.53
- BKE $54.25
- Technical
- Relative Strength Index (RSI)
- IBRX 29.17
- BKE 57.12
- Support Level
- IBRX $2.82
- BKE $50.58
- Resistance Level
- IBRX $3.18
- BKE $52.64
- Average True Range (ATR)
- IBRX 0.28
- BKE 1.31
- MACD
- IBRX -0.23
- BKE -0.37
- Stochastic Oscillator
- IBRX 1.25
- BKE 31.34
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.